Mediation analysis of the relationship between sex, cardiovascular risk factors and mortality from coronary heart disease: Findings from the population-based VHM&PP cohort

Atherosclerosis

Volumn 243, Issue 1, 2015, Pages 86-92

  Fritz, Josef ^a   Edlinger, Michael ^a   Kelleher, Cecily ^b   Strohmaier, Susanne ^c   Nagel, Gabriele ^d,e   Concin, Hans ^e   Ruttmann, Elfriede ^a   Hochleitner, Margarethe ^a   Ulmer, Hanno ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF ULM   (Germany)

^e AGENCY FOR PREVENTIVE AND SOCIAL MEDICINE   (Austria)

Author keywords

Cardiovascular disease risk factors; Coronary heart disease; Epidemiology; Gender; Mediation analysis; Sex

Indexed keywords

CHOLESTEROL; GLUCOSE; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; AUSTRIA; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DYING; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; SURVIVAL; SYSTOLIC BLOOD PRESSURE; ANALYSIS; BLOOD; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COMPLICATION; CORONARY ARTERY DISEASE; GLUCOSE BLOOD LEVEL; METABOLISM; MORTALITY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

AUSTRIA; BLOOD GLUCOSE; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; CHOLESTEROL; COHORT STUDIES; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX FACTORS;

EID: 84941067477     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.08.048     Document Type: Article

References (48)

1. Lozano R., Naghavi M., Foreman K., Lim S., Shibuya K., Aboyans V., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2095-2128. 10.1016/S0140-6736(12)61728-0.
2. Lerner D.J., Kannel W.B. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am. Heart J. 1986, 111:383-390. 10.1016/0002-8703(86)90155-9.
3. Shaw L.J., Bairey Merz C.N., Pepine C.J., Reis S.E., Bittner V., Kelsey S.F., et al. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J. Am. Coll. Cardiol. 2006, 47:S4-S20. 10.1016/j.jacc.2005.01.072.
4. Nichols M., Townsend N., Scarborough P., Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur. Heart J. 2014, 35:2950-2959. 10.1093/eurheartj/ehu299.
5. Kannel W.B., Levy D. Menopause, hormones, and cardiovascular vulnerability in women. Arch. Intern Med. 2004, 164:479-481. 10.1001/archinte.164.5.479.
6. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333. 10.1001/jama.288.3.321.
7. Schooling C.M. Testosterone and cardiovascular disease. Curr. Opin. Endocrinol. Diabetes Obes. 2014, 21:202-208. 10.1097/MED.0000000000000065.
8. Anand S.S., Islam S., Rosengren A., Franzosi M.G., Steyn K., Yusufali A.H., et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur. Heart J. 2008, 29:932-940. 10.1093/eurheartj/ehn018.
9. Barrett-Connor E. Gender differences and disparities in all-cause and coronary heart disease mortality: epidemiological aspects. Best. Pract. Res. Clin. Endocrinol. Metab. 2013, 27:481-500. 10.1016/j.beem.2013.05.013.
10. Mosca L., Barrett-Connor E., Wenger N.K. Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation 2011, 124:2145-2154. 10.1161/CIRCULATIONAHA.110.968792.
11. Ulmer H., Kelleher C., Diem G., Concin H. Why Eve is not Adam: prospective follow-up in 149650 women and men of cholesterol and other risk factors related to cardiovascular and all-cause mortality. J. Womens Health (Larchmt) 2004, 13:41-53. 10.1089/154099904322836447.
12. Pierce J.P. International comparisons of trends in cigarette smoking prevalence. Am. J. Public Health 1989, 79:152-157. 10.2105/AJPH.79.2.152.
13. World Health Organization WHO Report on the Global Tobacco Epidemic 2013, WHO, Geneva, Switzerland, Available from:, (accessed 18.08.2015). http://www.who.int/tobacco/global_report/2013/en/.
14. Wong N.D., Thakral G., Franklin S.S., L'Italien G.J.L., Jacobs M.J., Whyte J.L., et al. Preventing heart disease by controlling hypertension: impact of hypertensive subtype, stage, age ,and sex. Am. Heart J. 2003, 145:888-895. 10.1016/S0002-8703(02)00078-9.
15. Cheng S., Claggett B., Correia A.W., Shah A.M., Gupta D.K., Skali H., et al. Temporal trends in the population attributable risk for cardiovascular disease: the Atherosclerosis Risk in Communities Study. Circulation 2014, 130:820-828. 10.1161/CIRCULATIONAHA.113.008506.
16. Lu Y., Hajifathalian K., Ezzati M., Woodward M., Rimm E.B., Danaei G. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet 2014, 383:970-983. 10.1016/S0140-6736(13)61836-X.
17. Bogers R.P., Bemelmans W.J.E., Hoogenveen R.T., Boshuizen H.C., Woodward M., Knekt P., et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch. Intern Med. 2007, 167:1720-1728. 10.1001/archinte.167.16.1720.
18. Lear S.A., Chockalingam A., Kohli S., Richardson C.G., Humphries K.H. Elevation in cardiovascular disease risk in South Asians is mediated by differences in visceral adipose tissue. Obesity (Silver Spring) 2012, 20:1293-1300. 10.1038/oby.2011.395.
19. Baron R.M., Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J. Pers. Soc. Psychol. 1986, 51:1173-1182. 10.1037/0022-3514.51.6.1173.
20. Lange T., Hansen J.V. Direct and indirect effects in a survival context. Epidemiology 2011, 22:575-581. 10.1097/EDE.0b013e31821c680c.
21. Kaufman J.S., Maclehose R.F., Kaufman S. A further critique of the analytic strategy of adjusting for covariates to identify biologic mediation. Epidemiol. Perspect. Innov. 2004, 1:4. 10.1186/1742-5573-1-4.
22. Lange T., Vansteelandt S., Bekaert M. A simple unified approach for estimating natural direct and indirect effects. Am. J. Epidemiol. 2012, 176:190-195. 10.1093/aje/kwr525.
23. Lange T., Rasmussen M., Thygesen L.C. Assessing natural direct and indirect effects through multiple pathways. Am. J. Epidemiol. 2014, 179:513-518. 10.1093/aje/kwt270.
24. Nordahl H., Rod N.H., Frederiksen B.L., Andersen I., Lange T., Diderichsen F., et al. Education and risk of coronary heart disease: assessment of mediation by behavioral risk factors using the additive hazards model. Eur. J. Epidemiol. 2013, 28:149-157. 10.1007/s10654-012-9745-z.
25. Oberaigner W., Stühlinger W. Record linkage in the Cancer Registry of Tyrol, Austria. Methods Inf. Med. 2005, 44:626-630.
26. Gaensbacher S., Waldhoer T., Berzlanovich A. The slow death of autopsies: a retrospective analysis of the autopsy prevalence rate in Austria from 1990 to 2009. Eur. J. Epidemiol. 2012, 27:577-580. 10.1007/s10654-012-9709-3.
27. Ulmer H., Kelleher C., Diem G., Concin H. Long-term tracking of cardiovascular risk factors among men and women in a large population-based health system the Vorarlberg Health Monitoring & Promotion Programme. Eur. Heart J. 2003, 24:1004-1013. 10.1016/S0195-668X(03)00170-2.
28. Pearl J. Direct and indirect effects. Proceedings of the Seventeenth Conference on Uncertainty and Artificial Intelligence 2005, 1572-1581. MIRA Digital Publishing, Brentwood, MO, (Technical report R-273).
29. Perk J., De Backer G., Gohlke H., Graham I., Reiner Z., Verschuren M., et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur. Heart J. 2012, 33:1635-1701. 10.1093/eurheartj/ehs092.
30. Szklo M., Nieto J. Epidemiology: Beyond the Basics 2012, Jones & Bartlett Learning. third ed.
31. Weisberg S. Applied Linear Regression 2014, Wiley. fourth ed.
32. R Core Team R: A Language and Environment for Statistical Computing 2013, R Foundation for Statistical Computing, Vienna, Austria, (accessed 18.08.2015). http://www.R-project.org/.
33. Singh G.M., Danaei G., Farzadfar F., Stevens G.A., Woodward M., Wormser D., et al. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One 2013, 8:e65174. 10.1371/journal.pone.0065174.
34. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952. 10.1016/S0140-6736(04)17018-9.
35. Khalil R.A. Sex hormones as potential modulators of vascular function in hypertension. Hypertension 2005, 46:249-254. 10.1161/01.HYP.0000172945.06681.a4.
36. Maric-Bilkan C., Manigrasso M.B. Sex differences in hypertension: contribution of the renin-angiotensin system. Gend. Med. 2012, 9:287-291. 10.1016/j.genm.2012.06.005.
37. Barton M. Cholesterol and atherosclerosis: modulation by oestrogen. Curr. Opin. Lipidol. 2013, 24:214-220. 10.1097/MOL.0b013e3283613a94.
38. Casanova G., Bossardi Ramos R., Ziegelmann P., Mara Spritzer P. Effects of low-dose versus placebo or conventional dose postmenopausal hormone therapy on variables related to cardiovascular risk: a systematic review and meta-analyses of randomized clinical trials. J. Clin. Endocrinol. Metab. 2014, 100. 10.1210/jc.2014-3301.
39. Main C., Knight B., Moxham T., Gabriel Sanchez R., Sanchez Gomez L.M., Roqué i Figuls M., et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst. Rev. 2013, 4:CD002229. 10.1002/14651858.CD002229.pub3.
40. Zhao J., Jiang C., Lam T.H., Liu B., Cheng K.K., Xu L., et al. Genetically predicted testosterone and cardiovascular risk factors in men: a Mendelian randomization analysis in the Guangzhou Biobank Cohort Study. Int. J. Epidemiol. 2014, 43:140-148. 10.1093/ije/dyt239.
41. Xu L., Freeman G., Cowling B.J., Schooling C.M. Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med. 2013, 11:108. 10.1186/1741-7015-11-108.
42. Health Canada, Summary Safety Review-testosterone Replacement Products - Cardiovascular Risk. Available from: (accessed 18.08.2015). http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/testosterone-eng.php.
43. Meade T.W., Dyer S., Howarth D.J., Imeson J.D., Stirling Y. Antithrombin III and procoagulant activity: sex differences and effects of the menopause. Br. J. Haematol. 1990, 74:77-81. 10.1111/j.1365-2141.1990.tb02541.x.
44. Conroy R.M., Pyörälä K., Fitzgerald A.P., Sans S., Menotti A., De Backer G., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur. Heart J. 2003, 24:987-1003. 10.1016/S0195-668X(03)00114-3.
45. D'Agostino R.B., Vasan R.S., Pencina M.J., Wolf P.A., Cobain M., Massaro J.M., et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 117:743-753. 10.1161/CIRCULATIONAHA.107.699579.
46. Lewington S., Clarke R., Qizilbash N., Peto R., Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913. 10.1016/s0140-6736(03)13064-4.
47. Lewington S., Whitlock G., Clarke R., Sherliker P., Emberson J., Halsey J., et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007, 370:1829-1839. 10.1016/S0140-6736(07)61778-4.
48. Ahmad O.B., Boschi-Pinto C., Lopez A.D., Murray C.J.L., Lozano R., Inoue M. Age Standardization of Rates: A New WHO Standard 2001, WHO, Geneva, Switzerland, Available from:, (accessed 18.08.2015). http://www.who.int/healthinfo/paper31.pdf.